您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Cholic acid sodium
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Cholic acid sodium
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Cholic acid sodium图片
CAS NO:361-09-1
包装与价格:
包装价格(元)
10 mM * 1 mL in Water电议
100mg电议
200mg电议
500mg电议

产品名称
胆酸钠
产品介绍
Cholic acid sodium 是肝脏中产生的主要胆汁酸,通常与甘氨酸或牛磺酸缀合,有助于脂肪吸收和胆固醇排泄。Cholic acid sodium 具有口服活性。
生物活性

Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption andcholesterolexcretion. Cholic acid sodium is orally active[1][2].

IC50& Target

Human Endogenous Metabolite

 

体外研究
(In Vitro)

Cholic acid (1 mg/mL, 30 min) competitively binds Na+/taurocholate cotransporting polypeptide (NTCP) on HepG2 cells and significantly inhibits the uptake of Cholic acid (CA)-nanoliposomes (LPs)-Doxorubicin (DOX)-HCl, which indicates that CA-LPs-DOX-HCl are also uptaken via NTCP-mediated endocytosis pathway[1].

体内研究
(In Vivo)

Cholic acid (1% (w/w) Cholic acid-supplemented diet; p.o.; 14 days) decreases SHP (small heterodimer partner) protein expression, potentially via the upregulation of miR142-3p. Cholic acid increases CYP2D6 expression and activity[2].

Animal Model:Tg-CYP2D6adult male mice (8 weeks of age and weighing 20–25 g)[2]
Dosage:1% (w/w) Cholic acid-supplemented diet
Administration:Oral, 14 days
Result:Decreases SHP expression and increased CYP2D6 activity.
Clinical Trial
分子量

430.55

性状

Solid

Formula

C24H39NaO5

CAS 号

361-09-1

中文名称

胆酸钠

结构分类
  • Steroids
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

H2O : ≥ 250 mg/mL(580.65 mM)

*"≥" means soluble, but saturation unknown.

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.3226 mL11.6131 mL23.2261 mL
5 mM0.4645 mL2.3226 mL4.6452 mL
10 mM0.2323 mL1.1613 mL2.3226 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 100 mg/mL (232.26 mM); Clear solution; Need ultrasonic

*以上所有助溶剂都可在本网站选购。